clinical trial · NCT06778031
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase2·recruiting·n = 54
HER2-positive Locally Advanced or Metastatic Biliary Tract CancerSHR-A1811SHR-1316SHR-8068
brief summary
This study is an open, multicenter Phase II clinical trial to evaluate the efficacy and safety of the SHR-A1811 combination in HER2 positive patients with locally advanced or metastatic biliary tract cancer.
started
Feb 26, 2025
primary completion
Jun 1, 2028
completion
Sep 1, 2028
last updated
Mar 6, 2025
official title
An Open, Multicenter Phase II Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol